| Literature DB >> 34855078 |
S A Afanas'ev1, D S Kondrat'eva2, E F Muslimova2, О V Budnikova2, Sh D Akhmedov2, B N Kozlov2.
Abstract
We compared the expression of Са2+-ATPase (SERCA2a), calsequestrin (CASQ2), ryanodine receptors (RyR2) proteins and their genes (ATP2A2, CASQ2, and RYR2) in coronary heart disease (CHD) patients with and without comorbid type 2 diabetes mellitus. All studies were performed on the right atrial appendages resected during coronary bypass surgeries. Expression of SERCA2a and RyR2 proteins and their ATP2A2 (p=0.046) and RYR2 genes in comorbid pathology was significantly (p=0.042) higher (by 1.2 and 2 times; p=0.025). The expression of CASQ2 protein and its gene did not differ significantly between the groups (p=0.82 and p=0.066, respectively). It was concluded that the expression of SERCA2a and RyR2 proteins and their genes (but not CASQ2 and its gene) is elevated in CHD associated with type 2 diabetes mellitus. Expression of the studied proteins correlated with the expression of their genes. Increased expression of CASQ2 protein and its gene can probably prevent imbalance of the Ca2+-transporting systems in cardiomyocytes and contractile dysfunction of the myocardium, even in CHD associated with type 2 diabetes mellitus.Entities:
Keywords: ATP2A2, CASQ2, RYR2 gene expression; cardiomyocyte sarcoplasmic reticulum; coronary heart disease associated with type 2 diabetes mellitus; Са2+-transporter proteins
Mesh:
Substances:
Year: 2021 PMID: 34855078 DOI: 10.1007/s10517-021-05346-6
Source DB: PubMed Journal: Bull Exp Biol Med ISSN: 0007-4888 Impact factor: 0.804